Please login to the form below

Not currently logged in
Email:
Password:

statutory price control

This page shows the latest statutory price control news and features for those working in and with pharma, biotech and healthcare.

UK government tables bill on medicine pricing reforms

UK government tables bill on medicine pricing reforms

A central objective in the shake-up is to remove disparities between the voluntary Pharmaceutical Price Regulation Scheme (PPRS) and the statutory price control system for branded drugs sold by companies ... in "a fairer outcome for companies in the

Latest news

  • UK plans to cut some drug prices by up to 20 per cent UK plans to cut some drug prices by up to 20 per cent

    The Department of Health (DH) launched a consultation on revisions to the statutory scheme to control prices of branded medicine used on the NHS, which includes drugs not priced using the ... This statutory price control scheme was launched in 2008 to

  • Major progress on PPRS

    patent-expired medicines (where a generic equivalent is available) and a further variable price cut to deliver savings of 5 per cent. ... The new PPRS is being put forward as a non-contractual scheme, but the DH has launched a consultation on statutory

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics